Markets
LH

Labcorp Closes Acquisition Of Privately-held Personal Genome Diagnostics

February 21, 2022 — 07:09 am EST

Written by RTTNews.com for RTTNews->

(RTTNews) - Laboratory Corporation of America Holdings (LH) said that it has closed its acquisition of privately-held Personal Genome Diagnostics Inc, a provider of comprehensive liquid biopsy and tissue-based genomic products and services.

In December 2021, Laboratory Corporation of America Holdings said that it signed an agreement to buy Personal Genome Diagnostics Inc.

As part of the deal, Labcorp would pay $450 million in cash at closing and up to an additional $125 million on achieving future performance milestones.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

Stocks mentioned

LH

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.